Literature DB >> 22571973

Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease.

Dionysios Liveris1, Ira Schwartz, Donna McKenna, John Nowakowski, Robert Nadelman, Joseph Demarco, Radha Iyer, Susan Bittker, Denise Cooper, Diane Holmgren, Gary P Wormser.   

Abstract

Lyme disease, the most commonly reported tick-borne infection in North America, is caused by infection with the spirochete Borrelia burgdorferi. Although an accurate clinical diagnosis can often be made based on the presence of erythema migrans, in research studies microbiologic or molecular microbiologic confirmation of the diagnosis may be required. In this study, we evaluated the sensitivity of 5 direct diagnostic methods (culture and nested polymerase chain reaction [PCR] of a 2-mm skin biopsy specimen, nested PCR and quantitative PCR (qPCR) performed on the same 1-mL aliquot of plasma and a novel qPCR-blood culture method) in 66 untreated adult patients with erythema migrans. Results of one or more of these tests were positive in 93.9% of the patients. Culture was more sensitive than PCR for both skin and blood, but the difference was only statistically significant for blood samples (P<0.005). Blood culture was significantly more likely to be positive in patients with multiple erythema migrans skin lesions compared to those with a single lesion (P=0.001). Positive test results among the 48 patients for whom all 5 assays were performed invariably included either a positive blood or a skin culture. The results of this study demonstrate that direct detection methods such as PCR and culture are highly sensitive in untreated adult patients with erythema migrans. This enabled microbiologic or molecular microbiologic confirmation of the diagnosis of B. burgdorferi infection in all but 4 (6.1%) of the 66 patients evaluated.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22571973      PMCID: PMC3377843          DOI: 10.1016/j.diagmicrobio.2012.03.026

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  12 in total

1.  Improving the yield of blood cultures from patients with early Lyme disease.

Authors:  Dionysios Liveris; Ira Schwartz; Susan Bittker; Denise Cooper; Radha Iyer; Mary E Cox; Gary P Wormser
Journal:  J Clin Microbiol       Date:  2011-04-13       Impact factor: 5.948

Review 2.  Erythema migrans.

Authors:  Patricia Dandache; Robert B Nadelman
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

3.  Polymerase chain reaction amplification of culture supernatants for rapid detection of Borrelia burgdorferi.

Authors:  I Schwartz; S Bittker; S L Bowen; D Cooper; C Pavia; G P Wormser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-11       Impact factor: 3.267

4.  Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease.

Authors:  Kathryn L Jones; Lisa J Glickstein; Nitin Damle; Vijay K Sikand; Gail McHugh; Allen C Steere
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

5.  Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings.

Authors:  Dionysios Liveris; Guiqing Wang; Gary Girao; Daniel W Byrne; John Nowakowski; Donna McKenna; Robert Nadelman; Gary P Wormser; Ira Schwartz
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 6.  Diagnosis of lyme borreliosis.

Authors:  Maria E Aguero-Rosenfeld; Guiqing Wang; Ira Schwartz; Gary P Wormser
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

7.  Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques.

Authors:  J Nowakowski; I Schwartz; D Liveris; G Wang; M E Aguero-Rosenfeld; G Girao; D McKenna; R B Nadelman; L F Cavaliere; G P Wormser
Journal:  Clin Infect Dis       Date:  2001-11-07       Impact factor: 9.079

8.  Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction.

Authors:  J L Goodman; J F Bradley; A E Ross; P Goellner; A Lagus; B Vitale; B W Berger; S Luger; R C Johnson
Journal:  Am J Med       Date:  1995-07       Impact factor: 4.965

9.  Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin.

Authors:  B W Berger; R C Johnson; C Kodner; L Coleman
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

10.  Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions.

Authors:  I Schwartz; G P Wormser; J J Schwartz; D Cooper; P Weissensee; A Gazumyan; E Zimmermann; N S Goldberg; S Bittker; G L Campbell; C S Pavia
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

View more
  29 in total

1.  CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Authors:  John N Aucott; Mark J Soloski; Alison W Rebman; Lauren A Crowder; Lauren J Lahey; Catriona A Wagner; William H Robinson; Kathleen T Bechtold
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

Review 2.  Laboratory diagnosis of Lyme disease: advances and challenges.

Authors:  Adriana R Marques
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

3.  Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.

Authors:  John A Branda; Klemen Strle; Lise E Nigrovic; Paul M Lantos; Timothy J Lepore; Nitin S Damle; Mary Jane Ferraro; Allen C Steere
Journal:  Clin Infect Dis       Date:  2017-04-15       Impact factor: 9.079

4.  Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation.

Authors:  Claudia R Molins; Christopher Sexton; John W Young; Laura V Ashton; Ryan Pappert; Charles B Beard; Martin E Schriefer
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

5.  Surveillance for and Discovery of Borrelia Species in US Patients Suspected of Tickborne Illness.

Authors:  Luke C Kingry; Melissa Anacker; Bobbi Pritt; Jenna Bjork; Laurel Respicio-Kingry; Gongping Liu; Sarah Sheldon; David Boxrud; Anna Strain; Stephanie Oatman; Jon Berry; Lynne Sloan; Paul Mead; David Neitzel; Kiersten J Kugeler; Jeannine M Petersen
Journal:  Clin Infect Dis       Date:  2018-06-01       Impact factor: 9.079

Review 6.  Studies that report unexpected positive blood cultures for Lyme borrelia - are they valid?

Authors:  Gary P Wormser; Eugene D Shapiro; Franc Strle
Journal:  Diagn Microbiol Infect Dis       Date:  2017-07-29       Impact factor: 2.803

7.  Citrate Anticoagulant Improves the Sensitivity of Borreliella (Borrelia) burgdorferi Plasma Culture.

Authors:  Adriana R Marques; Xiuli Yang; Alexis A Smith; Xuran Zhuang; Siu-Ping Turk; Carla D Williams; Melissa A Law; Alan G Barbour; Utpal Pal
Journal:  J Clin Microbiol       Date:  2017-09-06       Impact factor: 5.948

8.  Lyme disease.

Authors:  Eugene D Shapiro
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

9.  Development of a metabolic biosignature for detection of early Lyme disease.

Authors:  Claudia R Molins; Laura V Ashton; Gary P Wormser; Ann M Hess; Mark J Delorey; Sebabrata Mahapatra; Martin E Schriefer; John T Belisle
Journal:  Clin Infect Dis       Date:  2015-03-11       Impact factor: 9.079

10.  T2 Magnetic Resonance Assay-Based Direct Detection of Three Lyme Disease-Related Borrelia Species in Whole-Blood Samples.

Authors:  Jessica L Snyder; Heidi Giese; Cheryl Bandoski-Gralinski; Jessica Townsend; Beck E Jacobson; Robert Shivers; Anna M Schotthoefer; Thomas R Fritsche; Clayton Green; Steven M Callister; John A Branda; Thomas J Lowery
Journal:  J Clin Microbiol       Date:  2017-05-31       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.